Mark J. Tullman, MD, board-certified neurologist specializing in the diagnosis and treatment of multiple sclerosis (MS), has joined The MS Center for Innovations in Care on the campus of Missouri Baptist Medical Center to help patients living with the chronic, often disabling affects of MS.  The Center at Missouri Baptist is designated as a National Multiple Sclerosis Society Affiliated Center for Comprehensive Care.

“I am extremely pleased to have Dr. Mark Tullman, a national leader in multiple sclerosis, joining our Center,” said Dr. Barry Singer, MD, director of the Center and a recognized leader in MS care in St. Louis.  “Dr. Tullman will help us to broaden our ability to provide comprehensive, forward-thinking care to more multiple sclerosis patients throughout the region and beyond." 

The MS Center for Innovations in Care launched in 2008 under the leadership of Dr. Singer.  The Center offers patients MS-certified nursing support, MS-certified physical and occupational therapy, clinical trial options and ongoing neurological care, The Center offers consultations also for other neurologists and patient-initiated second opinions. Information regarding multiple sclerosis, treatment options and the center can be found at www.mslivingwell.org, an award-winning web site including a national accolade for public service. 

A native St. Louisan, Dr. Tullman was formerly director of the Multiple Sclerosis Clinical Care Center for the Neurological Institute of New York at Columbia University Medical Center in New York City.  Prior to this position, he was assistant professor of neurology at Corinne Goldsmith Dickinson Center for Multiple Sclerosis (MS) at Mount Sinai School of Medicine in New York City. Tullman joined The MS Center for Innovations in Care at the end of July.

After earning his medical degree from the University of Missouri in Columbia, he completed his residency in internal medicine at Albert Einstein College of Medicine in Bronx, NY.  Thereafter, he completed his neurology residency and a postdoctoral fellowship in multiple sclerosis at Mount Sinai School of Medicine in New York City.

Board-certified in neurology, he specializes in all aspects of MS patient care, including treatment with the disease-modifying drugs and symptomatic therapies. He has been principal investigator for numerous MS clinical trials and he has published a variety of MS-related articles and book chapters. 

Dr. Tullman’s dedication to the field of MS was recognized when he was honored with the Sylvia Lawry Physician Fellowship award from the National Multiple Sclerosis Society and with the Martin S. Davis Multiple Sclerosis Fellow by the New York City Chapter of the National Multiple Sclerosis Society.

In addition to his memberships in the American Medical Association and the American Academy of Neurology, Dr. Tullman serves on the board of directors of MS Hope for a Cure and the editorial board of Continuum, the continuing medical education publication of the American Academy of Neurology.

Affecting more than 400,000 people in the U.S., MS attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another. Most people with MS are diagnosed between the ages of 20 and 50, with at least two times more women than men being diagnosed with the disease. 

Drs. Tullman and Singer are both members of BJC Medical Group of Missouri. The MS Center for Innovations in Care is located in Physicians’ Office Building B, Suite 207, Missouri Baptist Medical Center, 3009 North Ballas Road, St. Louis, Mo, 63131.

*Description by MS Center for Innovations in Care.